Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment reporting

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06607055Recruiting

Immunity Markers in Intensive Care Patients and Ventilator-associated Pneumonia

Role: lead

NCT07490028Completed

Variation in Viscoelastic Properties of Pulmonary Mucus in Patients Undergoing Mechanical Ventilation

Role: lead

NCT07741851Not ApplicableRecruiting

Monitoring of Neuromuscular Blockade in the Intensive Care Unit: a Reliability Study

Role: lead

NCT04352725Not ApplicableUnknown

Effect of PEEP Titration on the EELV Measured by the Nitrogen Dilution Technique in ARDS

Role: lead

All 4 trials loaded